FDA staff flags concerns about Pfizer's quit-smoking drug study

Sept 12 (Reuters) - U.S. Food and Drug Administration

scientists have expressed concerns about a post-marketing study

of Pfizer Inc's drug Chantix, which is aimed at helping

smokers quit, according...

Read more